Actithera closes $75.5m Series A to advance radioligand therapy platform

9th July 2025 Uncategorised 0

Funding to support lead candidate targeting FAP and pipeline expansion

More: Actithera closes .5m Series A to advance radioligand therapy platform
Source: News